Petros pharmaceuticals to present at the q1 investor summit conference

New york, march 03, 2022 (globe newswire) -- petros pharmaceuticals, inc. (nasdaq: ptpi), a leading provider of therapeutics for men's health, announces today that president and chief commercial officer fady boctor will present a corporate overview at the q1 investor summit conference, which is being held virtually on march 8 – 9, 2022.
PTPI Ratings Summary
PTPI Quant Ranking